|
POLQ expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.710600E-01 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.863600E-01 |
| Normal-vs-Stage2 |
6.556200E-02 |
| Normal-vs-Stage3 |
4.719200E-01 |
| Normal-vs-Stage4 |
7.359600E-01 |
| Stage1-vs-Stage2 |
2.32259999999318E-05 |
| Stage1-vs-Stage3 |
5.873400E-01 |
| Stage1-vs-Stage4 |
7.177200E-01 |
| Stage2-vs-Stage3 |
2.702100E-03 |
| Stage2-vs-Stage4 |
6.600000E-03 |
| Stage3-vs-Stage4 |
4.934400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.374200E-01 |
| Normal-vs-AfricanAmerican |
2.518800E-01 |
| Normal-vs-Asian |
5.487000E-01 |
| Caucasian-vs-AfricanAmerican |
1.045240E-01 |
| Caucasian-vs-Asian |
7.021600E-01 |
| AfricanAmerican-vs-Asian |
3.064000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.050400E-01 |
| Normal-vs-Female |
4.643800E-01 |
| Male-vs-Female |
8.735200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.760600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.896210E-01 |
| Normal-vs-Age(61-80Yrs) |
5.359400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.295400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.808800E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.246600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.612780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.240250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.562400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.639020E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.459600E-01 |
| Classical-VS-Follicular |
2.87949999999704E-06 |
| Classical-VS-Other |
3.217700E-02 |
| Classical-VS-Normal |
6.994200E-01 |
| Tall-VS-Follicular |
1.488270E-02 |
| Tall-VS-Other |
4.471900E-02 |
| Tall-VS-Normal |
9.756200E-01 |
| Follicular-VS-Other |
9.682600E-01 |
| Follicular-VS-Normal |
8.271800E-02 |
| Other-VS-Normal |
1.189210E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.329800E-01 |
| Normal-vs-N1 |
5.059000E-01 |
| N0-vs-N1 |
5.083400E-01 |
|
|
